G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability.
about
Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?Nkx2-5- and Isl1-expressing cardiac progenitors contribute to proepicardiumFog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart.The effect of the controlled release of basic fibroblast growth factor from ionic gelatin-based hydrogels on angiogenesis in a murine critical limb ischemic modelInducible cardiomyocyte-specific gene disruption directed by the rat Tnnt2 promoter in the mouseAdult mouse epicardium modulates myocardial injury by secreting paracrine factors.Genetic targeting of sprouting angiogenesis using Apln-CreER.Osteogenic progenitors in bone marrow aspirates have clinical potential for tibial non-unions healing in diabetic patients.Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats.Early and Long-term Effects of the Autologous Peripheral Stem Cell Implantation for Critical Limb Ischemia.VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activityEndothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora's box?Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy.Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases.Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation.A novel molecule Me6TREN promotes angiogenesis via enhancing endothelial progenitor cell mobilization and recruitment.Differentiation of hESCs into Mesodermal Subtypes: Vascular-, Hematopoietic- and Mesenchymal-lineage Cells.Transcriptional regulation of survivin by c-Myc in BCR/ABL-transformed cells: implications in anti-leukaemic strategy.Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization.Interleukin-27 enhances the production of tumour necrosis factor-α and interferon-γ by bone marrow T lymphocytes in aplastic anaemia.A Molecular and Clinical Review of Stem Cell Therapy in Critical Limb Ischemia.Prevention of diabetic microangiopathy by prophylactic transplant of mobilized peripheral blood mononuclear cells.Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans.
P2860
Q27015707-3CEA37A7-E18A-42C7-AB75-0C5554788785Q28590420-EAB3E7D6-4447-46A3-892C-0FC90E4454FBQ30487913-B71DC1DD-C8D7-47EB-A3A5-7BE85BCF11ADQ33275386-BC4C841F-6DF4-45D0-8924-210B5CE05EB6Q33590571-BA8F0C2F-1495-48CC-BAA2-789BDB7D8D42Q34875955-B0C4AAC2-8EC4-43A1-95BA-16C0586CE931Q35023052-1C8A8E57-973E-48FA-B577-24FCBC37AB73Q35842743-8EEE84CC-6D3F-41EB-A6E3-2B7AB7F753EFQ36097710-45721591-F584-49C8-A417-51236FC8513EQ36734655-849E6C43-9F1C-49FB-84CD-3E65A7A340DEQ36765584-AC361EB9-1C91-41A5-A3DD-700AFF0A6A22Q36933858-F60B032B-38D8-410C-93BE-2B8265984EF8Q37094023-50037F7B-0B69-41B3-AB29-C3018C2B1DFAQ37355158-1C74D21E-5B28-4F2F-80A5-3987B591D5C2Q37570669-61EE1365-F72A-4470-AC1E-26DFD3D43569Q37689954-96D14B57-BB95-4451-A342-368D41462B58Q37743869-B2F2800F-DC4B-490F-A1FD-CA274F964134Q38168212-6ADE3943-6656-459F-9205-AAAEEF59CC28Q39825470-39BCAF11-9CA6-4A59-87CE-6284C6A9E7BBQ39954061-992213FF-CC7F-4F4B-A6E7-BDAB77E7FAF2Q43693626-BBB14D95-BF62-473F-AED1-284DEF611641Q48189678-9D491D76-6BBA-4F42-AB68-08658F9E73CFQ51092118-0F65609F-F52A-4E59-B640-DAA7C1AB8F83Q53932544-4CE507C2-A704-40BF-B351-CE5E5931144E
P2860
G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
G-CSF-mobilized peripheral blo ...... but with impaired capability.
@en
G-CSF-mobilized peripheral blo ...... but with impaired capability.
@nl
type
label
G-CSF-mobilized peripheral blo ...... but with impaired capability.
@en
G-CSF-mobilized peripheral blo ...... but with impaired capability.
@nl
prefLabel
G-CSF-mobilized peripheral blo ...... but with impaired capability.
@en
G-CSF-mobilized peripheral blo ...... but with impaired capability.
@nl
P2093
P2860
P1476
G-CSF-mobilized peripheral blo ...... s but with impaired capability
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2006.01906.X
P577
2006-05-01T00:00:00Z